Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression

被引:10
作者
Delhem, Nadira [1 ]
Cottrez, Francoise [2 ]
Carpentier, Arnaud [1 ,3 ]
Miroux, Celine [1 ]
Morales, Olivier [1 ]
Francois, Violaine [1 ]
Groux, Herve [2 ]
Auriault, Claude [4 ]
Pancre, Veronique [1 ]
机构
[1] Inst Biol Lille, Lab Immunopathol Canc Viroinduits, UMR 8161, Lille, France
[2] Les Cyclades, Immunosearch, Grasse, France
[3] Inst Cochin Genet Mol, Immunol Lab, UPREZ 1833, F-75014 Paris, France
[4] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, Sophia Antipoli, France
关键词
HCV; hepatocarcinoma; T lymphocyte; cirrhosis; fibrosis;
D O I
10.1684/bdc.2008.0752
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatitis C virus (HCV) becomes chronic in about 85% of infected individuals, whereas only 15% of infected people clear spontaneously the virus. The progression of hepatitis C to chronic status is associated to a profound down-regulation of CD4 and CD8 multispecific immune response. This immune defect may participate to the immune tolerance of VHC and consequently to its persistence. Recent findings indicate that T regulatory cells as Tr1 play an inhibitory role on T helper responses notably in the context of auto-immune or inflammatory disorders. The existence of immunosuppressive mechanisms supported by Tr1 lymphocytes and their IL-10 production represent an attractive hypothesis. We have previously evaluated the existence of regulatory T cells (Tr1) via high production of IL-70, in liver biopsies of three well-defined cohorts of HCV-1b infected patients. To this purpose, we compared liver biopsies of chronically infected patients including patients without liver lesions, with cirrhosis and with hepatocellular carcinoma (HCC). Using quantitative real time PCR, the results obtained
引用
收藏
页码:1029 / 1038
页数:10
相关论文
共 26 条
[1]   Lack of evidence for the Th2 predominance in patients with chronic hepatitis C [J].
Bergamini, A ;
Bolacchi, F ;
Cerasari, G ;
Carvelli, C ;
Faggioli, E ;
Cepparulo, M ;
Demin, F ;
Uccella, I ;
Bongiovanni, B ;
Niutta, P ;
Capozzi, M ;
Lupi, M ;
Piscitelli, E ;
Rocchi, G ;
Angelico, M .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03) :451-458
[2]   Hepatitis B and C viruses and primary liver cancer [J].
Brechot, C .
BAILLIERES CLINICAL GASTROENTEROLOGY, 1996, 10 (02) :335-373
[3]   Analysis of a successful immune response against hepatitis C virus [J].
Cooper, S ;
Erickson, AL ;
Adams, EJ ;
Kansopon, J ;
Weiner, AJ ;
Chien, DY ;
Houghton, M ;
Parham, P ;
Walker, CM .
IMMUNITY, 1999, 10 (04) :439-449
[4]   Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C [J].
Cramp, ME ;
Rossol, S ;
Chokshi, S ;
Carucci, P ;
Williams, R ;
Naoumov, NV .
GASTROENTEROLOGY, 2000, 118 (02) :346-355
[5]  
Delpuech O, 2001, EUR CYTOKINE NETW, V12, P69
[6]   Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation [J].
Dolganiuc, A ;
Kodys, K ;
Kopasz, A ;
Marshall, C ;
Do, T ;
Romics, L ;
Mandrekar, P ;
Zapp, M ;
Szabo, G .
JOURNAL OF IMMUNOLOGY, 2003, 170 (11) :5615-5624
[7]  
Esquivel CA, 2002, REV INVEST CLIN, V54, P41
[8]   A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis [J].
Groux, H ;
OGarra, A ;
Bigler, M ;
Rouleau, M ;
Antonenko, S ;
deVries, JE ;
Roncarolo, MG .
NATURE, 1997, 389 (6652) :737-742
[9]   Effects of liver-derived dendritic cell progenitors on Th1-and Th2-like cytokine responses in vitro and in vivo [J].
Khanna, A ;
Morelli, AE ;
Zhong, CP ;
Takayama, T ;
Lu, L ;
Thomson, AW .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1346-1354
[10]   Role of ICAM-1 and P-selectin expression in the development and effector function of CD4+CD25+ regulatory T cells [J].
Kohm, AP ;
Miller, SD .
JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) :261-271